Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: Clinical aspects, predisposing factors, and differential pathogenicity of the causative strains

Clinical Infectious Diseases

Volumn 23, Issue 3, 1996, Pages 506-514

  Girmenia, Corrado ^b   Martine, Pietro ^b   De Bernardis, Flavia ^b   Gentile, Giuseppe ^b   Boccanera, Maria ^b   Monaco, Monica ^b   Antonucci, Giovanni ^b   Cassone, Antonio ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANTIFUNGAL ACTIVITY; ANTIGENICITY; ARTICLE; BACTEREMIA; BACTERIAL VIRULENCE; CANDIDA PARAPSILOSIS; CENTRAL VENOUS CATHETER; CLINICAL ARTICLE; ENDOCARDITIS; FEMALE; FUNGEMIA; HUMAN; INFECTION; MALE; MORTALITY; MULTIPLE ORGAN FAILURE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0029830085     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/23.3.506     Document Type: Article

References (13)

1. Kiehn TE, Edwards FF, Armstrong D. The prevalence of yeast in clinical specimens from cancer patients. Am J Clin Pathol 1980; 73:518-21.
2. Komshian SV, Uwaydah AK, Sobel JD, Crane LR. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing out-come. Rev Infect Dis 1989; 11:379-90.
3. Meunier-Carpentier F, Kiehn TE, Armstrong D. Fungemia in the immuno-compromised host: changing patterns, antigenemia, high mortality. Am J Med 1981; 71:363-70.
4. Dubois D, van Burik J-A, Davis C, Leisenring W, Bowden RA. Emergence of non-Candida albicans fungemia in bone marrow transplant (BMT) patients receiving fluconazole (FLU) prophylaxis [abstract no J6]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). Washington, DC: American Society for Microbiology, 1994:9.
5. Martino P, Girmenia C, Micozzi A, et al. Fungemia in patients with leukemia. Am J Med Sci 1993; 306:225-32.
6. Menichetti F, Del Favero A, Martino P, et al. Preventing fungal infection in neutropenic patients with acute leukemia: fluconazole compared with oral amphotericin B. Ann Intern Med 1994; 120:913-8.
7. Nguyen MH, Peacock JE, Morris AJ, et al. The changing face of candidemia: results of large scale prospective multicenter study [abstract no J107]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). Washington, DC: American Society for Microbiology, 1994:106.
8. Odds FC. Candida and candidosis. 2nd ed. London: Bailliere-Tyndall, 1988.
9. Vecchiarelli A, Bistoni F, Cenci E, Perito S, Cassone A. In-vitro killing of Candida species by murine immunoeffectors and its relationship to the experimental pathogenicity. Sabouraudia 1985; 23:377-87.
10. Plouffe JF, Brown DG, Silva J Jr, Eck T, Stricof RL, Fekety FR Jr. Nosocomial outbreak of Candida parapsilosis fungemia related to intravenous infusions. Arch Intern Med 1977; 137:1686-9.
11. Weems JJ Jr, Chamberland ME, Ward J, Willy M, Padhye AA, Solomon SL. Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. J Clin Microbiol 1987; 25:1029-32.
12. Weems JJ Jr. Candida parapsilosis: epidemiology, pathogenicity, clinical manifestations, and antimicrobial susceptibility. Clin Infect Dis 1992; 14:756-66.
13. Pfaller MA, Messer S, Hollis R. Genotypic variation, antifungal susceptibility and slime production among isolates of Candida parapsilosis [abstract no J104]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando). Washington, DC: American Society for Microbiology, 1994:105.